logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Nuclera Nucleics Ltd.


USPTO Granted Patents = 11


Trademarks = 4

Forward Citations = 4

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Michael C Chen (5 out of 8 patents)

silverMedal Gordon R McInroy (5 out of 13 patents)

bronzeMedal Jiahao Huang (4 out of 7 patents)

4.  Richard J Paolini, Jr (3 out of 168 patents)

5.  David Zhitomirsky (3 out of 8 patents)

6.  Radu A Lazar (3 out of 5 patents)

7.  Ian French (2 out of 33 patents)

8.  Cristina Visani (2 out of 10 patents)

9.  Seth J Bishop (1 out of 21 patents)

10.  Annie Tsai (1 out of 1 patent)

11.  Luke M Slominski (1 out of 25 patents)

12.  Gordon Ross Mcinroy (2 patents)

13.  Michael Chunhao Chen (0 patent)


11 patents:

1. 11623940 - Methods of nucleic acid synthesis comprising polyphosphate containing species (2023-04-11),
2. 11596946 - Segmented top plate for variable driving and short protection for digital microfluidics (2023-03-07),
3. 11554375 - Microfluidic devices containing reversibly pinned droplet samples and methods (2023-01-17),
4. 11554374 - Spatially variable dielectric layers for digital microfluidics (2023-01-17),
5. 11505815 - Compositions and methods related to non-templated enzymatic nucleic acid synthesis (2022-11-22),
6. 11466301 - Nucleotide triphosphate immobilised on a support and their use in nucleic acid synthesis (2022-10-11),
7. 11410621 - Latched transistor driving for high frequency ac driving of EWoD arrays (2022-08-09),
8. 11410620 - Adaptive gate driving for high frequency AC driving of EWoD arrays (2022-08-09),
9. 11353759 - Backplanes with hexagonal and triangular electrodes (2022-06-07),
10. 11236377 - Compositions and methods related to nucleic acid synthesis (2022-02-01),
11. 10745727 - Compositions and methods related to nucleic acid synthesis (2020-08-18),
Company Overview
Nuclera Nucleics Ltd. is a biotechnology company based in Cambridge, UK, specializing in the development of innovative solutions for DNA synthesis and genetic engineering. The company focuses on advancing synthetic biology through its proprietary technologies, which aim to enhance the efficiency and accessibility of DNA production. By leveraging cutting-edge research, Nuclera is positioned to contribute significantly to various applications in healthcare, agriculture, and industrial biotechnology, fostering advancements in genetic research and therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#90 in Cambridge

#1,598 in United Kingdom

#51,714 in the World

Cambridge, GB
Cambridge, United Kingdom

Nuclera Nucleics Ltd.

Forward Citations = 4

11 inventors:

goldMedal Michael C Chen (5 out of 8 patents)

silverMedal Gordon R McInroy (5 out of 13 patents)

bronzeMedal Jiahao Huang (4 out of 7 patents)

4.  Richard J Paolini, Jr (3 out of 168 patents)

5.  David Zhitomirsky (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nuclera Nucleics Ltd.. Retrieved from https://idiyas.com/company/nuclera-nucleics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…